Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2014 /
Adjuvant chemotherapy in elderly ER HER2- breast cancer patients

23rd - 25th Oct 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.11.14
Views: 2503

Dr Etienne Brain - Institut Curie, Paris, France

Dr Brain speaks to ecancertv at SIOG 2014 about the ASTER 70s phase III trial, examining the benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast cancer in women over 70 according to genomic grade.


Breast · Elderly · Complications · SIOG 2014

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation